{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:42:00Z","timestamp":1786545720796,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1111\/j.1572-0241.2008.02152.x","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T17:14:11Z","timestamp":1228238051000},"page":"3106-3114","source":"Crossref","is-referenced-by-count":50,"title":["Mesalamine Foam Enema\n                    <i>Versus<\/i>\n                    Mesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis"],"prefix":"10.14309","volume":"103","author":[{"given":"Antoine","family":"Cortot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Maetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Degoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Delette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Brice","family":"Cazals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dewit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Hebuterne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Beorchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Grunberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leprince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"D'Haens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Idier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00e9mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/BF01296108","article-title":"Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis","volume":"38","author":"Campieri","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.32.8.929","article-title":"Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis","volume":"32","author":"Campieri","year":"1991","journal-title":"Gut"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(81)90523-7","article-title":"Treatment of ulcerative colitis with high dose 5-aminosalicylic acid enema","volume":"2","author":"Campieri","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2036.1995.tb00384.x","article-title":"Rectal aminosalicylate therapy for distal ulcerative colitis: A meta-analysis","volume":"9","author":"Marshall","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00054725-199805000-00001","article-title":"Dose ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial. The US PENTASA Enema Study Group","volume":"4","author":"Hanauer","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/gut.34.5.676","article-title":"Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: A controlled trial","volume":"34","author":"Pullan","year":"1993","journal-title":"Gut"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/gut.38.2.229","article-title":"A randomised trial comparing mesalazine and prednisolone foam enemas in patients with active distal ulcerative colitis","volume":"38","author":"Lee","year":"1996","journal-title":"Gut"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2000.01940.x","article-title":"A meta-analysis and over view of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis","volume":"95","author":"Cohen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB9","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/BF01308084","article-title":"Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis","volume":"37","author":"Campieri","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2036.1999.00482.x","article-title":"A new mesalazine gel enema in the treatment of left sided ulcerative colitis: A randomized controlled multicentre trial","volume":"13","author":"Gionchetti","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB11","first-page":"677","article-title":"Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparison trial vs Salofalk enema. The SAF-3 study group","volume":"31","author":"Ardizzone","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2036.2002.01199.x","article-title":"A new mesalazine foam enema (Claversal foam) compared with a standard liquid enema in patients with active distal ulcerative colitis","volume":"16","author":"Malchow","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1365-2036.2000.00784.x","article-title":"Efficacy and tolerability of mesalazine foam (Salofalk foam) for distal ulcerative colitis: A double-blind, randomized, placebo-controlled study","volume":"14","author":"Pokrotnieks","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1365-2036.2007.03468.x","article-title":"Clinical trial: Randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis","volume":"26","author":"Eliakim","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB15","unstructured":"15.\u2002Clinical Study Report PPL 469 (Sept 2002). Ferring Pharmaceuticals, Mesalazine foam: Internal data. Unpublished results."},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial","volume":"289","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB17","unstructured":"17.\u2002European Medicines Agency. Evaluation of medicines for human use. London, 27 July 2005. Doc. Ref. EMEA\/CPMP\/EWP\/482\/99. Available at: http:\/\/www.emea.europa.eu\/pdfs\/human\/ewp\/048299en.pdf."},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB18","unstructured":"18.\u2002ICH Topic E9. Statistical principles for clinical trials. September 1998. Available at: http:\/\/www.fda.gov\/cder\/guidance\/index.htm."},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-amicosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiiditis, and proctitis","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","article-title":"Rectal corticosteroids versus alternative treatments in ulcerative colitis: A meta-analysis","volume":"40","author":"Marshall","year":"1997","journal-title":"Gut"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2036.1997.00183.x","article-title":"Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis","volume":"11","author":"Gionchetti","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clinical Gastroenterol Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB23","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB24","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1053\/j.gastro.2005.03.031","article-title":"A randomized, double blinded, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine","volume":"128","author":"Lemann","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB25","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1053\/j.gastro.2004.03.005","article-title":"Are claims of equivalence in digestive trials supported by evidence?","volume":"126","author":"Tinmouth","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB26","unstructured":"26.\u2002European Medicines Agency. Pre-authorisation evaluation of medicines for human use. London, 27 July 2005. Doc. Ref. EMEA\/CPMP\/EWP\/2158\/99. Available at: http:\/\/www.emea.europa.eu\/pdfs\/human\/ewp\/215899en.pdf."},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-2036.2004.02282.x","article-title":"Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis","volume":"20","author":"Raedler","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2036.2006.02743.x","article-title":"Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis","volume":"23","author":"Gross","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02152.x-BIB29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2006.02861.x","article-title":"Comparison of the efficacy and safety of Eudragit-L-cated mesalazine tablets with ethycellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis","volume":"23","author":"Gibson","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["The American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-200812000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:40Z","timestamp":1786542340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-200812000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02152.x","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}